Imperial College London

ProfessorFrederickTam

Faculty of MedicineDepartment of Immunology and Inflammation

Ken and Mary Minton Chair of Renal Medicine
 
 
 
//

Contact

 

+44 (0)20 3313 2354f.tam

 
 
//

Location

 

9N, 15C, Commonwealth BuildingHammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Tam:2017:10.15406/unoaj.2017.05.00171,
author = {Tam, FWK and Yap, HL and frankel, A},
doi = {10.15406/unoaj.2017.05.00171},
journal = {Urology and Nephology Open Access Journal},
title = {MCP-1: A potential target for diabetic microvascular complications?},
url = {http://dx.doi.org/10.15406/unoaj.2017.05.00171},
volume = {5},
year = {2017}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - MCP-1 is a potent chemokine with the ability to mobilize and stimulate leucocytes, especially monocytes and macrophages. It is increasingly recognized as an important player in the inflammatory process that is diabetic nephropathy. In this article, we describe its role in inducing renal injury by outlining key studies in animal models and clinical studies of diabetic nephropathy, its association with diabetic retinopathy, as well as its potential use as a prognostic biomarker and as a therapeutic target in the clinical setting.
AU - Tam,FWK
AU - Yap,HL
AU - frankel,A
DO - 10.15406/unoaj.2017.05.00171
PY - 2017///
SN - 2378-3176
TI - MCP-1: A potential target for diabetic microvascular complications?
T2 - Urology and Nephology Open Access Journal
UR - http://dx.doi.org/10.15406/unoaj.2017.05.00171
UR - http://hdl.handle.net/10044/1/54331
VL - 5
ER -